Filing Flows › DarioHealth (DRIO) › Q3 2025
DarioHealth (DRIO) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 13, 2025
DarioHealth (DRIO) reported revenue of $5.0M for the third quarter 2025 (Q3 2025), -33% from a year earlier and -7% from the quarter before. Operating margin was -189.4%, net loss $10.5M (209.0% of revenue).
DarioHealth, Q3 2025: revenue $5.0M (-32% year over year), operating margin -189.4%, net loss $10.5M, operating cash flow −$7.3M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.0M | -7% | -33% |
| Operating profit | −$9.5M | — | — |
| Net earnings | −$10.5M | — | — |
| Operating cash flow | −$7.3M | — | — |
What changed
Revenue was $5.0M in Q3 2025, down 33% year over year and down 7% from the previous quarter. Services was the largest line at 64% of revenue. Services lost $2.4M year over year (down 43%), 99% of the total change.
Gross margin was 60.2%, up 8.0 points from a year earlier. Operating costs exceeded revenue by $9.5M, an operating margin of -189.4%. Operating expenses fell 21% while revenue fell 33%. The fastest-growing cost line was General & admin (+23%). The quarter ended with a net loss of $10.5M, narrower than the previous quarter's $13.0M loss.
Operating cash flow was −$7.3M. Non-cash charges added back $546K of depreciation and amortization and $3.0M of share-based compensation. Working capital and other items used $380K. Capital expenditures of $41K exceeded it, leaving free cash flow of −$7.4M.
Questions
What was DarioHealth's revenue in the third quarter 2025?
DarioHealth (DRIO) reported revenue of $5.0M for the third quarter 2025 (Q3 2025), -33% from a year earlier and -7% from the quarter before.
Was DarioHealth profitable in the third quarter 2025?
Operating loss was $9.5M (-189.4% of revenue) and net loss $10.5M.
Source: DarioHealth 10-Q on SEC EDGAR.